iRhythm Technologies (IRTC) Financials

$142.24 +0.87 (+0.62%)

Closing price 04:00 PM Eastern

Extended Trading

$135.15 -7.09 (-4.98%)

As of 05:05 PM Eastern

Annual Income Statements for iRhythm Technologies

This table shows iRhythm Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-113	-123	-116	-101	-44	-55	-50	-30	-21	-23
Consolidated Net Income / (Loss)	-113	-123	-116	-101	-44	-55	-50	-30	-21	-23
Net Income / (Loss) Continuing Operations	-113	-123	-116	-101	-44	-55	-50	-30	-21	-23
Total Pre-Tax Income	-113	-123	-116	-101	-44	-55	-50	-30	-21	-23
Total Operating Income	-116	-125	-114	-100	-44	-55	-46	-28	-16	-22
Total Gross Profit	408	332	282	214	195	162	108	71	43	21
Total Revenue	592	493	411	323	265	215	147	99	64	36
Operating Revenue	592	493	411	323	265	215	147	99	64	36
Total Cost of Revenue	184	161	129	109	70	52	39	28	21	15
Operating Cost of Revenue	184	161	129	109	70	52	39	28	21	15
Total Operating Expenses	523	457	395	314	239	217	154	99	59	43
Selling, General & Admin Expense	419	386	322	275	197	180	133	85	52	37
Research & Development Expense	104	60	47	39	41	37	21	13	7.15	6.35
Restructuring Charge	0.64	11	27	0.00	-	-	-	-	-	-
Total Other Income / (Expense), net	2.78	2.51	-2.10	-1.05	0.07	0.25	-4.64	-2.15	-5.32	-1.06
Interest Expense	20	3.65	4.14	1.17	1.52	1.64	6.14	3.39	3.25	1.06
Interest & Investment Income	22	6.35	2.35	-	-	-	-	-	-	-
Other Income / (Expense), net	1.25	-0.20	-0.31	0.12	1.59	1.90	1.50	1.24	-2.07	-
Income Tax Expense	0.57	0.75	0.27	0.37	0.23	0.07	0.04	0.00	0.00	-
Basic Earnings per Share	($3.63)	($4.04)	($3.88)	($3.46)	($1.58)	($2.16)	($2.11)	($1.31)	($3.95)	($16.57)
Weighted Average Basic Shares Outstanding	31.20M	30.53M	29.92M	29.33M	27.75M	25.27M	23.89M	22.63M	5.29M	1.38M
Diluted Earnings per Share	($3.63)	($4.04)	($3.88)	($3.46)	($1.58)	($2.16)	($2.11)	($1.31)	($3.95)	($16.57)
Weighted Average Diluted Shares Outstanding	31.20M	30.53M	29.92M	29.33M	27.75M	25.27M	23.89M	22.63M	5.29M	1.38M
Weighted Average Basic & Diluted Shares Outstanding	31.41M	30.98M	30.22M	29.51M	27.75M	25.27M	23.89M	22.63M	5.29M	1.38M

This table shows iRhythm Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-31	-1.33	-46	-20	-46	-39	-27	-18	-39	-20	-21
Consolidated Net Income / (Loss)	-31	-1.33	-46	-20	-46	-39	-27	-18	-39	-20	-21
Net Income / (Loss) Continuing Operations	-31	-1.33	-46	-20	-46	-39	-27	-18	-39	-20	-21
Total Pre-Tax Income	-30	-1.18	-46	-20	-46	-38	-27	-18	-39	-20	-21
Total Operating Income	-33	-4.08	-50	-23	-38	-39	-28	-19	-40	-21	-21
Total Gross Profit	109	115	101	103	88	87	82	86	76	79	71
Total Revenue	159	164	148	148	132	133	125	124	111	113	104
Operating Revenue	159	164	148	148	132	133	125	124	111	113	104
Total Cost of Revenue	49	49	46	45	44	45	42	38	36	34	33
Operating Cost of Revenue	49	49	46	45	44	45	42	38	36	34	33
Total Operating Expenses	142	119	152	126	126	127	110	105	115	99	92
Selling, General & Admin Expense	120	100	103	107	109	100	94	91	100	87	81
Research & Development Expense	22	19	48	20	17	15	16	14	15	13	11
Total Other Income / (Expense), net	2.52	2.90	4.31	3.07	-7.50	0.74	0.68	0.60	0.48	0.57	-0.25
Interest Expense	3.27	3.32	3.33	3.31	10	0.94	0.93	0.83	0.95	1.01	0.61
Interest & Investment Income	4.92	-	6.46	-	-	-	1.72	-	-	-	0.37
Other Income / (Expense), net	0.88	-9.26	1.18	6.38	2.95	-2.96	-0.11	1.44	1.43	-	-
Income Tax Expense	0.67	0.15	0.19	0.19	0.03	0.26	0.20	0.21	0.09	0.07	0.12
Basic Earnings per Share	($0.97)	($0.03)	($1.48)	($0.65)	($1.47)	($1.25)	($0.89)	($0.61)	($1.29)	($0.66)	($0.71)
Weighted Average Basic Shares Outstanding	31.59M	31.20M	31.26M	31.15M	31.03M	30.53M	30.61M	30.50M	30.30M	29.92M	30.06M
Diluted Earnings per Share	($0.97)	($0.03)	($1.48)	($0.65)	($1.47)	($1.25)	($0.89)	($0.61)	($1.29)	($0.66)	($0.71)
Weighted Average Diluted Shares Outstanding	31.59M	31.20M	31.26M	31.15M	31.03M	30.53M	30.61M	30.50M	30.30M	29.92M	30.06M
Weighted Average Basic & Diluted Shares Outstanding	31.93M	31.41M	31.30M	31.24M	31.10M	30.98M	30.65M	30.58M	30.47M	30.22M	30.11M

This table details how cash moves in and out of iRhythm Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	392	-43	-49	39	0.44	11	-43	26	17
Net Cash From Operating Activities	3.39	-50	-23	-38	-22	-29	-15	-17	-18
Net Cash From Continuing Operating Activities	3.39	-50	-23	-38	-22	-29	-15	-17	-18
Net Income / (Loss) Continuing Operations	-113	-123	-116	-101	-55	-50	-30	-21	-23
Consolidated Net Income / (Loss)	-113	-123	-116	-101	-55	-50	-30	-21	-23
Depreciation Expense	21	16	13	9.84	3.45	2.27	1.60	0.57	0.49
Amortization Expense	6.51	0.77	5.77	8.39	8.11	-0.70	-0.09	0.26	0.12
Non-Cash Adjustments To Reconcile Net Income	180	152	136	92	51	33	21	10	3.02
Changes in Operating Assets and Liabilities, net	-91	-96	-62	-46	-30	-13	-7.21	-6.73	1.16
Net Cash From Investing Activities	-123	-1.21	-52	105	-89	34	-35	-68	-1.79
Net Cash From Continuing Investing Activities	-123	-1.21	-52	105	-89	34	-35	-68	-1.79
Purchase of Property, Plant & Equipment	-34	-40	-30	-28	-20	-5.18	-3.56	-2.76	-1.79
Acquisitions	-15	0.00	0.00	-	-	-	-	-	-
Purchase of Investments	-175	-167	-189	-122	-166	-93	-130	-65	-
Sale and/or Maturity of Investments	101	207	166	256	97	132	99	-	-
Net Cash From Financing Activities	511	8.82	27	-29	112	6.30	6.53	111	36
Net Cash From Continuing Financing Activities	511	8.82	27	-29	112	6.30	6.53	111	36
Repayment of Debt	-136	0.00	-21	-12	0.00	-34	0.00	-	-4.91
Repurchase of Common Equity	-25	0.00	0.00	-	-	-	-	-	-
Issuance of Debt	736	0.00	35	0.00	-	35	0.00	-	29
Issuance of Common Equity	8.47	8.82	13	8.94	9.50	9.32	-	114	-
Other Financing Activities, net	-72	0.00	0.00	-26	102	-3.88	6.53	-3.18	0.30
Other Net Changes in Cash	-0.01	-0.17	0.00	-	-	-	-	-	-
Cash Interest Paid	6.39	2.96	3.32	1.19	1.64	6.07	1.55	1.59	0.34
Cash Income Taxes Paid	0.92	1.13	0.29	0.00	-	-	-	-	-

This table details how cash moves in and out of iRhythm Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-44	-100	-31	30	493	-11	-14	8.77	-26	7.61	-30
Net Cash From Operating Activities	-7.89	19	24	12	-52	-16	1.20	-4.57	-31	13	3.67
Net Cash From Continuing Operating Activities	-7.89	19	24	12	-52	-16	1.20	-4.57	-31	13	3.67
Net Income / (Loss) Continuing Operations	-31	-1.33	-46	-20	-46	-39	-27	-18	-39	-20	-21
Consolidated Net Income / (Loss)	-31	-1.33	-46	-20	-46	-39	-27	-18	-39	-20	-21
Depreciation Expense	5.21	5.29	5.14	5.16	5.13	4.91	4.07	3.79	3.58	3.48	3.44
Amortization Expense	1.57	1.82	2.02	1.75	0.91	0.14	0.08	0.32	0.23	0.69	-3.15
Non-Cash Adjustments To Reconcile Net Income	50	34	64	40	43	51	33	28	40	27	35
Changes in Operating Assets and Liabilities, net	-34	-20	-0.65	-15	-55	-33	-8.98	-19	-35	1.46	-10
Net Cash From Investing Activities	-38	-122	-55	15	40	1.40	-15	9.01	3.82	-8.11	-35
Net Cash From Continuing Investing Activities	-38	-122	-55	15	40	1.40	-15	9.01	3.82	-8.11	-35
Purchase of Property, Plant & Equipment	-9.42	-6.84	-8.83	-8.49	-9.78	-14	-9.09	-9.40	-8.42	-7.09	-6.33
Purchase of Investments	-34	-118	-40	-15	-2.43	-55	-36	-42	-34	-51	-46
Sale and/or Maturity of Investments	5.60	2.50	8.50	38	52	70	30	61	46	50	17
Net Cash From Financing Activities	1.73	2.99	-0.04	3.79	505	3.47	0.07	4.38	0.91	3.15	1.66
Net Cash From Continuing Financing Activities	1.73	2.99	-0.04	3.79	505	3.47	0.07	4.38	0.91	3.15	1.66
Repayment of Debt	0.00	-	-0.18	-0.95	-135	-	-	-	0.00	-	-
Repurchase of Common Equity	0.00	-	-	-	-25	-	-	-	0.00	-	-
Issuance of Debt	0.00	-	-	-	736	-	-	-	0.00	-	-
Issuance of Common Equity	1.73	2.99	0.15	4.73	0.60	3.47	0.07	4.38	0.91	3.15	1.66
Other Financing Activities, net	0.00	-	-	-	-72	-	-	-	0.00	-	-
Other Net Changes in Cash	-0.02	0.00	0.01	-0.01	-0.00	-0.20	0.08	-0.04	0.00	-	-
Cash Interest Paid	4.96	-	4.79	-	1.60	0.77	0.77	0.74	0.68	0.64	0.46
Cash Income Taxes Paid	0.39	0.32	0.24	0.35	0.01	0.34	0.51	0.28	0.01	0.29	-

This table presents iRhythm Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	931	433	448	463	512	306	118	133	138	38
Total Current Assets	646	231	289	306	378	173	104	120	119	33
Cash & Equivalents	420	36	79	128	89	20	20	-	52	25
Short-Term Investments	116	98	134	112	247	120	58	-	54	-
Accounts Receivable	80	61	50	46	30	24	20	13	9.41	5.58
Inventories, net	14	14	15	10	5.31	4.04	2.06	-	1.39	1.15
Prepaid Expenses	16	22	11	9.69	7.36	4.34	4.10	-	1.67	0.81
Plant, Property, & Equipment, net	125	104	76	56	34	26	9.16	6.30	4.65	2.04
Total Noncurrent Assets	161	98	84	102	100	107	4.07	0.00	15	3.01
Long-Term Investments	62	3.00	-	-	-	8.03	0.00	-	11	-
Goodwill	0.86	0.86	0.86	0.86	0.86	0.86	0.86	-	0.86	0.86
Other Noncurrent Operating Assets	98	94	83	101	99	98	3.21	-	3.05	2.15
Total Liabilities & Shareholders' Equity	931	433	448	463	512	306	118	133	138	38
Total Liabilities	841	223	208	183	170	171	65	70	46	42
Total Current Liabilities	111	107	89	88	66	52	30	21	13	8.78
Accounts Payable	7.22	5.54	7.52	11	4.37	8.24	2.28	-	2.10	1.46
Accrued Expenses	85	83	65	51	41	33	27	16	10	6.70
Current Deferred Revenue	2.93	3.31	3.05	3.05	0.93	1.25	1.22	-	0.95	0.51
Other Current Liabilities	16	15	13	11	8.17	7.91	0.00	-	-	-
Total Noncurrent Liabilities	730	116	119	96	104	119	35	54	32	34
Long-Term Debt	646	35	35	9.69	21	33	35	-	32	31
Other Noncurrent Operating Liabilities	83	81	84	86	83	86	0.00	54	0.13	3.05
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Equity & Noncontrolling Interests	91	210	240	280	342	135	52	-157	93	-102
Total Preferred & Common Equity	91	210	240	280	342	135	52	79	93	-102
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Common Equity	91	210	240	280	342	135	52	-157	93	-102
Common Stock	875	856	762	686	646	396	258	-	220	4.64
Retained Earnings	-759	-646	-522	-406	-305	-260	-206	-157	-127	-106
Treasury Stock	-25	0.00	-	-	-	-	-	-	-	-
Accumulated Other Comprehensive Income / (Loss)	0.17	-0.11	-0.40	-0.06	0.01	0.08	-0.02	-	-0.01	-

This table presents iRhythm Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	926	910	919	910	440	429	422	440
Total Current Assets	636	628	678	687	234	242	254	286
Cash & Equivalents	375	520	551	520	47	62	53	71
Short-Term Investments	145	2.50	11	49	111	103	124	132
Accounts Receivable	81	77	86	90	50	51	50	61
Inventories, net	14	15	15	15	14	14	16	14
Prepaid Expenses	20	13	15	14	12	12	12	7.33
Plant, Property, & Equipment, net	131	122	118	112	97	90	82	72
Total Noncurrent Assets	159	159	124	110	109	98	86	83
Long-Term Investments	63	59	-	-	-	-	-	-
Goodwill	0.86	0.86	0.86	0.86	0.86	0.86	0.86	0.86
Other Noncurrent Operating Assets	96	99	123	109	108	97	85	82
Total Liabilities & Shareholders' Equity	926	910	919	910	440	429	422	440
Total Liabilities	839	838	820	819	220	206	200	201
Total Current Liabilities	111	100	98	97	102	89	82	84
Accounts Payable	12	7.59	13	8.44	7.21	7.15	9.78	7.40
Accrued Expenses	80	74	66	70	77	64	55	60
Current Deferred Revenue	3.28	3.03	3.15	3.07	3.38	3.70	3.49	3.00
Other Current Liabilities	16	16	15	15	15	14	14	13
Total Noncurrent Liabilities	728	738	722	723	118	116	118	118
Long-Term Debt	647	646	645	644	35	35	35	35
Other Noncurrent Operating Liabilities	81	92	77	79	83	81	83	83
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	87	72	99	90	220	224	222	239
Total Preferred & Common Equity	87	72	99	90	220	224	222	239
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	87	72	99	90	220	224	222	239
Common Stock	901	854	835	807	827	804	783	742
Retained Earnings	-790	-758	-711	-691	-607	-580	-561	-502
Treasury Stock	-25	-25	-25	-25	-	-	-	-
Accumulated Other Comprehensive Income / (Loss)	0.14	-0.07	0.18	-0.09	-0.02	-0.15	-0.07	-0.68

This table displays calculated financial ratios and metrics derived from iRhythm Technologies' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.13%	19.90%	27.29%	21.74%	23.59%	45.68%	48.57%	54.72%	77.29%	66.17%
EBITDA Growth	19.60%	-14.03%	-16.34%	-184.07%	30.47%	3.07%	-71.51%	-47.65%	19.94%	-45.87%
EBIT Growth	8.86%	-9.87%	-14.30%	-137.22%	20.39%	-19.62%	-67.68%	-49.27%	18.38%	-46.50%
NOPAT Growth	7.71%	-10.00%	-13.85%	-128.84%	20.24%	-19.84%	-65.60%	-77.07%	27.96%	-46.50%
Net Income Growth	8.20%	-6.24%	-14.60%	-131.26%	19.68%	-8.32%	-69.39%	-42.28%	8.32%	-44.01%
EPS Growth	10.15%	-4.12%	-12.14%	-118.99%	26.85%	-2.37%	-61.07%	66.84%	76.16%	-37.51%
Operating Cash Flow Growth	106.77%	-117.72%	39.05%	-174.39%	37.07%	24.85%	-95.11%	10.45%	7.52%	-15.22%
Free Cash Flow Firm Growth	16.25%	-68.90%	13.86%	-91.45%	5.94%	44.00%	-334.27%	320.28%	-11.02%	0.00%
Invested Capital Growth	29.19%	75.78%	-0.22%	56.70%	81.06%	146.39%	117.41%	-761.54%	817.11%	0.00%
Revenue Q/Q Growth	5.68%	4.21%	8.11%	0.94%	8.03%	8.78%	9.66%	11.34%	0.00%	0.00%
EBITDA Q/Q Growth	21.98%	-19.61%	9.74%	-36.33%	24.18%	-5.74%	-1.54%	-24.19%	0.00%	0.00%
EBIT Q/Q Growth	16.42%	-17.51%	8.93%	-29.74%	15.29%	-8.71%	-1.49%	-25.51%	0.00%	0.00%
NOPAT Q/Q Growth	23.31%	-17.33%	9.18%	-29.25%	15.72%	-9.25%	-4.94%	-31.40%	0.00%	0.00%
Net Income Q/Q Growth	24.80%	-17.64%	9.57%	-29.09%	14.86%	-1.92%	-10.53%	-21.20%	0.00%	0.00%
EPS Q/Q Growth	25.15%	-17.10%	10.39%	-29.59%	18.13%	0.00%	0.00%	-123.99%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	110.66%	-132.45%	52.68%	-123.52%	47.96%	-2.28%	-2.29%	-22.97%	21.85%	0.00%
Free Cash Flow Firm Q/Q Growth	22.78%	-33.86%	16.28%	-22.71%	23.03%	52.05%	-346.99%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	2.49%	12.48%	-12.76%	-2.53%	-6.75%	36.94%	115.80%	-536.34%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.86%	67.35%	68.54%	66.16%	73.50%	75.54%	73.66%	71.55%	67.41%	59.32%
EBITDA Margin	-14.70%	-21.97%	-23.10%	-25.27%	-10.83%	-19.25%	-28.94%	-25.07%	-26.27%	-58.17%
Operating Margin	-19.52%	-25.40%	-27.69%	-30.96%	-16.47%	-25.52%	-31.02%	-27.83%	-24.32%	-59.85%
EBIT Margin	-19.30%	-25.44%	-27.77%	-30.92%	-15.87%	-24.64%	-30.00%	-26.59%	-27.55%	-59.85%
Profit (Net Income) Margin	-19.14%	-25.05%	-28.27%	-31.40%	-16.53%	-25.43%	-34.21%	-30.00%	-32.62%	-63.09%
Tax Burden Percent	100.50%	100.61%	100.23%	100.36%	100.53%	100.12%	100.09%	100.00%	100.00%	100.48%
Interest Burden Percent	98.66%	97.84%	101.57%	101.17%	103.61%	103.11%	113.90%	112.85%	118.40%	104.90%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-65.16%	-103.14%	-129.15%	-138.34%	-99.97%	-250.57%	0.00%	0.00%	-256.55%	-3,622.42%
ROIC Less NNEP Spread (ROIC-NNEP)	57.64%	-77.58%	-110.71%	-126.26%	-93.59%	-229.88%	0.00%	0.00%	-231.42%	-3,907.92%
Return on Net Nonoperating Assets (RNNOA)	-10.12%	48.28%	84.42%	105.70%	81.59%	192.38%	0.00%	0.00%	209.07%	4,629.44%
Return on Equity (ROE)	-75.27%	-54.86%	-44.73%	-32.64%	-18.38%	-58.19%	96.27%	92.59%	-47.49%	1,007.02%
Cash Return on Invested Capital (CROIC)	-90.63%	-158.10%	-128.93%	-182.52%	-157.65%	-335.09%	-1,036.41%	0.00%	-417.23%	-3,822.42%
Operating Return on Assets (OROA)	-16.75%	-28.45%	-25.04%	-20.48%	-10.29%	-24.95%	-35.22%	-19.41%	-20.06%	-57.12%
Return on Assets (ROA)	-16.60%	-28.00%	-25.50%	-20.80%	-10.72%	-25.76%	-40.16%	-21.91%	-23.75%	-60.20%
Return on Common Equity (ROCE)	-75.27%	-54.86%	-44.73%	-32.64%	-18.38%	-58.19%	96.27%	92.59%	4.89%	22,601.08%
Return on Equity Simple (ROE_SIMPLE)	-124.62%	-58.74%	-48.44%	-36.26%	-12.83%	-40.30%	-96.63%	-37.48%	-22.58%	22.43%
Net Operating Profit after Tax (NOPAT)	-81	-88	-80	-70	-31	-38	-32	-19	-11	-15
NOPAT Margin	-13.66%	-17.78%	-19.38%	-21.67%	-11.53%	-17.86%	-21.72%	-19.48%	-17.02%	-41.90%
Net Nonoperating Expense Percent (NNEP)	-122.80%	-25.56%	-18.44%	-12.08%	-6.38%	-20.69%	58.60%	98.43%	-25.14%	285.51%
Return On Investment Capital (ROIC_SIMPLE)	-10.97%	-35.75%	-28.99%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	31.14%	32.65%	31.46%	33.84%	26.50%	24.46%	26.34%	28.45%	32.59%	40.68%
SG&A Expenses to Revenue	70.72%	78.27%	78.41%	85.14%	74.38%	83.67%	90.52%	86.00%	80.57%	101.61%
R&D to Revenue	17.54%	12.23%	11.34%	11.98%	15.59%	17.38%	14.16%	13.38%	11.16%	17.57%
Operating Expenses to Revenue	88.37%	92.75%	96.23%	97.11%	89.97%	101.06%	104.68%	99.38%	91.73%	119.18%
Earnings before Interest and Taxes (EBIT)	-114	-125	-114	-100	-42	-53	-44	-26	-18	-22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-87	-108	-95	-82	-29	-41	-43	-25	-17	-21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	31.04	15.62	11.76	12.39	20.05	13.39	32.23	0.00	7.17	0.00
Price to Tangible Book Value (P/TBV)	31.34	15.68	11.80	12.43	20.10	13.47	32.77	0.00	7.24	0.00
Price to Revenue (P/Rev)	4.77	6.66	6.86	10.73	25.83	8.45	11.41	12.99	10.36	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	20.52	29.36	42.89	52.56	166.15	78.09	185.32	0.00	75.51	0.00
Enterprise Value to Revenue (EV/Rev)	4.85	6.45	6.43	10.05	24.69	7.92	11.11	12.99	9.04	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	846.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	32.97	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	7.11	0.17	0.15	0.08	0.10	0.26	0.67	0.00	0.35	-6.75
Long-Term Debt to Equity	7.11	0.17	0.15	0.03	0.06	0.24	0.67	0.00	0.35	-6.75
Financial Leverage	-0.18	-0.62	-0.76	-0.84	-0.87	-0.84	-0.60	-0.33	-0.90	-1.18
Leverage Ratio	4.53	1.96	1.75	1.57	1.71	2.26	-2.40	-4.23	2.00	-8.36
Compound Leverage Factor	4.47	1.92	1.78	1.59	1.78	2.33	-2.73	-4.77	2.37	-8.77
Debt to Total Capital	87.67%	14.26%	12.72%	7.10%	8.81%	20.51%	40.10%	0.00%	25.83%	117.40%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	3.88%	3.11%	1.14%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	87.67%	14.26%	12.72%	3.22%	5.70%	19.37%	40.10%	0.00%	25.83%	117.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	373.10%
Common Equity to Total Capital	12.33%	85.74%	87.28%	92.90%	91.19%	79.49%	59.90%	100.00%	74.17%	-390.50%
Debt to EBITDA	-7.43	-0.32	-0.37	-0.26	-1.15	-0.85	-0.82	0.00	-1.91	-1.45
Net Debt to EBITDA	-0.56	0.94	1.88	2.67	10.52	2.75	1.02	0.00	5.04	-0.25
Long-Term Debt to EBITDA	-7.43	-0.32	-0.37	-0.12	-0.74	-0.80	-0.82	0.00	-1.91	-1.45
Debt to NOPAT	-8.00	-0.40	-0.44	-0.31	-1.08	-0.91	-1.09	0.00	-2.95	-2.02
Net Debt to NOPAT	-0.61	1.16	2.24	3.11	9.89	2.97	1.36	0.00	7.78	-0.35
Long-Term Debt to NOPAT	-8.00	-0.40	-0.44	-0.14	-0.70	-0.86	-1.09	0.00	-2.95	-2.02
Altman Z-Score	1.79	7.26	7.10	10.65	24.30	5.78	13.73	10.35	8.40	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	110.29%	-2,144.35%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.82	2.15	3.24	3.48	5.75	3.32	3.44	5.60	8.98	3.74
Quick Ratio	5.55	1.82	2.95	3.25	5.56	3.16	3.24	0.61	8.74	3.51
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-112	-134	-80	-92	-48	-51	-92	39	-18	-16
Operating Cash Flow to CapEx	9.99%	-123.94%	-77.14%	-134.51%	-101.53%	-106.87%	-561.64%	-418.61%	-602.64%	-1,007.55%
Free Cash Flow to Firm to Interest Expense	-5.51	-36.79	-19.21	-78.96	-31.74	-31.20	-14.90	11.54	-5.46	-15.09
Operating Cash Flow to Interest Expense	0.17	-13.73	-5.56	-32.30	-9.06	-13.31	-4.74	-4.40	-5.13	-17.00
Operating Cash Flow Less CapEx to Interest Expense	-1.50	-24.80	-12.77	-56.30	-17.98	-25.76	-5.58	-5.46	-5.98	-18.69
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.87	1.12	0.90	0.66	0.65	1.01	1.17	0.73	0.73	0.95
Accounts Receivable Turnover	8.37	8.85	8.53	8.46	9.86	9.83	8.95	8.80	8.55	6.48
Inventory Turnover	13.16	11.05	10.17	14.02	15.03	17.21	0.00	0.00	16.48	12.84
Fixed Asset Turnover	5.16	5.48	6.24	7.16	8.74	12.05	19.06	18.11	19.16	17.75
Accounts Payable Turnover	28.88	24.64	14.34	14.69	11.15	9.97	0.00	0.00	11.73	10.08
Days Sales Outstanding (DSO)	43.61	41.27	42.79	43.17	37.03	37.14	40.80	41.50	42.68	56.33
Days Inventory Outstanding (DIO)	27.74	33.04	35.89	26.03	24.28	21.21	0.00	0.00	22.15	28.43
Days Payable Outstanding (DPO)	12.64	14.82	25.44	24.84	32.74	36.60	0.00	0.00	31.13	36.23
Cash Conversion Cycle (CCC)	58.71	59.49	53.23	44.35	28.57	21.74	40.80	41.50	33.70	48.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	140	108	62	62	39	22	8.83	-51	7.67	0.84
Invested Capital Turnover	4.77	5.80	6.66	6.38	8.67	14.03	-7.03	-4.61	15.07	86.46
Increase / (Decrease) in Invested Capital	32	47	-0.14	22	18	13	60	-58	6.83	0.84
Enterprise Value (EV)	2,871	3,179	2,642	3,245	6,546	1,699	1,637	1,288	579	0.00
Market Capitalization	2,822	3,281	2,820	3,463	6,849	1,813	1,680	1,288	664	0.00
Book Value per Share	$2.90	$6.85	$7.96	$9.50	$11.83	$5.09	$2.16	($6.82)	$4.18	($73.85)
Tangible Book Value per Share	$2.88	$6.83	$7.94	$9.47	$11.80	$5.05	$2.12	($6.82)	$4.14	($74.48)
Total Capital	737	245	275	301	375	170	87	-157	125	26
Total Debt	646	35	35	21	33	35	35	0.00	32	31
Total Long-Term Debt	646	35	35	9.69	21	33	35	0.00	32	31
Net Debt	49	-102	-178	-218	-302	-114	-43	0.00	-85	5.25
Capital Expenditures (CapEx)	34	40	30	28	14	20	5.18	3.56	2.76	1.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.65	-10	-13	-9.80	-11	-18	-4.38	98	-0.75	-1.25
Debt-free Net Working Capital (DFNWC)	535	123	200	229	324	123	74	98	105	24
Net Working Capital (NWC)	535	123	200	218	312	121	74	98	105	24
Net Nonoperating Expense (NNE)	32	36	37	31	13	16	18	10	10.00	7.66
Net Nonoperating Obligations (NNO)	49	-102	-178	-218	-302	-114	-43	106	-85	5.36
Total Depreciation and Amortization (D&A)	27	17	19	18	13	12	1.57	1.51	0.83	0.61
Debt-free, Cash-free Net Working Capital to Revenue	-0.11%	-2.10%	-3.28%	-3.03%	-4.30%	-8.33%	-2.98%	99.24%	-1.17%	-3.44%
Debt-free Net Working Capital to Revenue	90.38%	25.06%	48.59%	71.04%	122.12%	57.18%	50.22%	99.24%	164.49%	66.56%
Net Working Capital to Revenue	90.38%	25.06%	48.59%	67.43%	117.72%	56.27%	50.22%	99.24%	164.49%	66.56%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.63)	($4.04)	($3.88)	($3.46)	($1.58)	($2.16)	($2.02)	($1.30)	($3.95)	($16.57)
Adjusted Weighted Average Basic Shares Outstanding	31.20M	30.53M	29.92M	29.33M	29.16M	26.80M	24.46M	23.45M	22.15M	1.38M
Adjusted Diluted Earnings per Share	($3.63)	($4.04)	($3.88)	($3.46)	($1.58)	($2.16)	($2.02)	($1.30)	($3.95)	($16.57)
Adjusted Weighted Average Diluted Shares Outstanding	31.20M	30.53M	29.92M	29.33M	29.16M	26.80M	24.46M	23.45M	22.15M	1.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($1.58)	($2.16)	($2.02)	($1.30)	($3.95)	($16.57)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.41M	30.98M	30.22M	29.51M	27.75M	25.27M	23.89M	22.63M	5.29M	1.38M
Normalized Net Operating Profit after Tax (NOPAT)	-80	-80	-61	-70	-31	-38	-32	-19	-11	-15
Normalized NOPAT Margin	-13.59%	-16.21%	-14.85%	-21.67%	-11.53%	-17.86%	-21.72%	-19.48%	-17.02%	-41.90%
Pre Tax Income Margin	-19.05%	-24.90%	-28.20%	-31.28%	-16.44%	-25.40%	-34.18%	-30.00%	-32.62%	-62.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-5.60	-34.34	-27.57	-85.39	-27.70	-32.17	-7.19	-7.78	-5.44	-20.43
NOPAT to Interest Expense	-3.96	-24.00	-19.25	-59.85	-20.13	-23.33	-5.21	-5.70	-3.36	-14.30
EBIT Less CapEx to Interest Expense	-7.26	-45.42	-34.78	-109.40	-36.62	-44.62	-8.04	-8.84	-6.29	-22.11
NOPAT Less CapEx to Interest Expense	-5.62	-35.08	-26.46	-83.86	-29.05	-35.78	-6.05	-6.76	-4.21	-15.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-22.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from iRhythm Technologies' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.27%	24.01%	18.41%	19.27%	18.39%	17.67%	19.96%	21.64%	20.63%	37.67%	21.59%
EBITDA Growth	22.66%	83.20%	-78.11%	27.30%	14.96%	-124.33%	-13.31%	29.31%	10.79%	38.95%	-11.98%
EBIT Growth	17.16%	68.33%	-77.26%	4.79%	7.58%	-103.59%	-31.42%	25.65%	21.55%	35.69%	9.73%
NOPAT Growth	14.64%	89.58%	-82.24%	-21.77%	3.46%	-89.30%	-30.91%	19.53%	18.63%	35.72%	9.43%
Net Income Growth	32.77%	96.56%	-70.31%	-8.79%	-16.77%	-91.60%	-26.41%	22.66%	22.72%	37.84%	9.61%
EPS Growth	34.01%	97.60%	-66.29%	-6.56%	-13.95%	-89.39%	-25.35%	23.75%	24.56%	40.54%	12.35%
Operating Cash Flow Growth	84.83%	220.41%	1,935.70%	358.97%	-69.18%	-227.00%	-67.40%	-1,129.03%	20.91%	196.40%	-79.24%
Free Cash Flow Firm Growth	92.75%	53.48%	-67.75%	-225.05%	-200.52%	-416.41%	-104.11%	-138.03%	-34.57%	68.02%	41.06%
Invested Capital Growth	-8.90%	29.19%	41.79%	94.20%	105.47%	75.78%	36.32%	25.31%	13.33%	-0.22%	11.48%
Revenue Q/Q Growth	-3.44%	11.38%	-0.34%	12.22%	-0.44%	6.35%	0.38%	11.39%	-1.05%	8.42%	1.79%
EBITDA Q/Q Growth	-299.66%	85.15%	-333.10%	66.75%	14.61%	-57.38%	-76.79%	61.11%	-106.76%	20.51%	-10.30%
EBIT Q/Q Growth	-137.42%	72.83%	-195.89%	52.82%	10.20%	-52.07%	-58.92%	54.20%	-83.94%	1.84%	10.08%
NOPAT Q/Q Growth	-697.35%	91.88%	-118.89%	39.74%	2.66%	-41.95%	-46.26%	52.23%	-90.86%	1.84%	10.08%
Net Income Q/Q Growth	-2,203.08%	97.11%	-129.68%	55.97%	-18.01%	-42.72%	-46.72%	52.74%	-93.63%	5.84%	10.24%
EPS Q/Q Growth	-3,133.33%	97.97%	-127.69%	55.78%	-17.60%	-40.45%	-45.90%	52.71%	-95.45%	7.04%	11.25%
Operating Cash Flow Q/Q Growth	-141.03%	-21.01%	105.63%	122.76%	-225.75%	-1,435.45%	126.16%	85.13%	-344.54%	242.76%	1,086.29%
Free Cash Flow Firm Q/Q Growth	76.55%	54.31%	27.95%	6.12%	-44.65%	-64.78%	-39.61%	13.20%	-158.62%	34.87%	-62.81%
Invested Capital Q/Q Growth	7.63%	2.49%	-25.29%	10.55%	48.52%	12.48%	2.32%	16.97%	30.57%	-12.76%	-5.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.83%	70.02%	68.78%	69.89%	66.34%	65.98%	66.19%	69.46%	67.91%	69.89%	68.28%
EBITDA Margin	-15.69%	-3.79%	-28.44%	-6.55%	-22.09%	-27.98%	-18.91%	-10.74%	-30.75%	-14.68%	-20.02%
Operating Margin	-20.52%	-2.48%	-34.09%	-15.52%	-28.91%	-29.57%	-22.15%	-15.20%	-35.45%	-18.38%	-20.30%
EBIT Margin	-19.97%	-8.12%	-33.29%	-11.21%	-26.67%	-31.80%	-22.24%	-14.05%	-34.16%	-18.38%	-20.30%
Profit (Net Income) Margin	-19.35%	-0.81%	-31.30%	-13.58%	-34.61%	-29.20%	-21.76%	-14.89%	-35.10%	-17.94%	-20.65%
Tax Burden Percent	102.21%	112.78%	100.41%	100.97%	100.07%	100.66%	100.72%	101.17%	100.22%	100.36%	100.54%
Interest Burden Percent	94.80%	8.86%	93.63%	119.95%	129.70%	91.23%	97.15%	104.77%	102.50%	97.23%	101.18%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-56.26%	-8.30%	-114.84%	-42.17%	-84.53%	-120.05%	-87.86%	-56.88%	-140.94%	-85.72%	-80.64%
ROIC Less NNEP Spread (ROIC-NNEP)	-67.65%	-14.07%	-77.53%	-24.79%	-27.40%	-112.00%	-82.53%	-53.36%	-133.67%	-82.84%	-77.30%
Return on Net Nonoperating Assets (RNNOA)	-53.10%	2.47%	15.63%	3.55%	5.83%	69.71%	52.52%	34.09%	90.30%	63.16%	57.95%
Return on Equity (ROE)	-109.35%	-5.83%	-99.21%	-38.62%	-78.70%	-50.34%	-35.34%	-22.79%	-50.64%	-22.56%	-22.69%
Cash Return on Invested Capital (CROIC)	-39.41%	-90.63%	-125.15%	-128.73%	-139.59%	-158.10%	-120.23%	-105.36%	-109.34%	-128.93%	-141.79%
Operating Return on Assets (OROA)	-13.45%	-7.04%	-27.63%	-8.93%	-20.56%	-35.55%	-23.89%	-14.68%	-34.55%	-16.58%	-16.76%
Return on Assets (ROA)	-13.04%	-0.70%	-25.98%	-10.82%	-26.68%	-32.65%	-23.38%	-15.56%	-35.49%	-16.18%	-17.05%
Return on Common Equity (ROCE)	-109.35%	-5.83%	-99.21%	-38.62%	-78.70%	-50.34%	-35.34%	-22.79%	-50.64%	-22.56%	-22.69%
Return on Equity Simple (ROE_SIMPLE)	-113.45%	0.00%	-209.93%	-132.66%	-143.94%	0.00%	-47.73%	-44.33%	-47.18%	0.00%	-53.69%
Net Operating Profit after Tax (NOPAT)	-23	-2.86	-35	-16	-27	-27	-19	-13	-28	-14	-15
NOPAT Margin	-14.36%	-1.74%	-23.87%	-10.87%	-20.24%	-20.70%	-15.51%	-10.64%	-24.82%	-12.87%	-14.21%
Net Nonoperating Expense Percent (NNEP)	11.39%	5.77%	-37.32%	-17.37%	-57.13%	-8.05%	-5.34%	-3.52%	-7.27%	-2.88%	-3.34%
Return On Investment Capital (ROIC_SIMPLE)	-3.11%	-0.39%	-	-	-	-11.19%	-	-	-	-5.27%	-
Cost of Revenue to Revenue	31.17%	29.98%	31.22%	30.11%	33.66%	34.02%	33.81%	30.54%	32.09%	30.11%	31.72%
SG&A Expenses to Revenue	75.60%	60.71%	70.07%	72.11%	82.36%	75.55%	75.25%	73.65%	90.05%	77.01%	77.55%
R&D to Revenue	13.75%	11.80%	32.37%	13.30%	12.88%	11.63%	13.09%	11.02%	13.32%	11.26%	11.02%
Operating Expenses to Revenue	89.35%	72.51%	102.87%	85.41%	95.24%	95.55%	88.34%	84.67%	103.36%	88.27%	88.57%
Earnings before Interest and Taxes (EBIT)	-32	-13	-49	-17	-35	-42	-28	-17	-38	-21	-21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-25	-6.23	-42	-9.69	-29	-37	-24	-13	-34	-17	-21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	37.94	31.04	32.31	33.76	39.38	15.62	13.11	14.20	16.89	11.76	15.72
Price to Tangible Book Value (P/TBV)	38.32	31.34	32.71	34.05	39.76	15.68	13.16	14.25	16.96	11.80	15.78
Price to Revenue (P/Rev)	5.32	4.77	4.14	6.23	6.93	6.66	6.10	7.03	8.72	6.86	9.90
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	22.26	20.52	17.46	18.78	21.97	29.36	28.66	32.41	44.83	42.89	50.88
Enterprise Value to Revenue (EV/Rev)	5.42	4.85	4.26	6.39	7.07	6.45	5.84	6.74	8.39	6.43	9.45
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	70.52	846.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	7.47	7.11	9.00	6.50	7.13	0.17	0.16	0.16	0.16	0.15	0.15
Long-Term Debt to Equity	7.47	7.11	9.00	6.50	7.13	0.17	0.16	0.16	0.16	0.15	0.15
Financial Leverage	0.78	-0.18	-0.20	-0.14	-0.21	-0.62	-0.64	-0.64	-0.68	-0.76	-0.75
Leverage Ratio	10.37	4.53	4.63	4.17	4.27	1.96	1.92	1.85	1.82	1.75	1.72
Compound Leverage Factor	9.84	0.40	4.33	5.01	5.53	1.79	1.86	1.93	1.87	1.71	1.74
Debt to Total Capital	88.19%	87.67%	90.00%	86.67%	87.71%	14.26%	13.72%	13.50%	13.61%	12.72%	12.74%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	88.19%	87.67%	90.00%	86.67%	87.71%	14.26%	13.72%	13.50%	13.61%	12.72%	12.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	11.81%	12.33%	10.00%	13.33%	12.30%	85.74%	86.28%	86.50%	86.39%	87.28%	87.26%
Debt to EBITDA	-8.12	-7.43	-5.79	-6.93	-6.66	-0.32	-0.39	-0.40	-0.39	-0.37	-0.33
Net Debt to EBITDA	-0.80	-0.56	-0.58	-0.90	-0.77	0.94	1.37	1.48	1.60	1.88	1.60
Long-Term Debt to EBITDA	-8.12	-7.43	-5.79	-6.93	-6.66	-0.32	-0.39	-0.40	-0.39	-0.37	-0.33
Debt to NOPAT	-8.41	-8.00	-6.13	-7.20	-7.43	-0.40	-0.47	-0.50	-0.48	-0.44	-0.40
Net Debt to NOPAT	-0.83	-0.61	-0.61	-0.93	-0.87	1.16	1.65	1.85	1.93	2.24	1.92
Long-Term Debt to NOPAT	-8.41	-8.00	-6.13	-7.20	-7.43	-0.40	-0.47	-0.50	-0.48	-0.44	-0.40
Altman Z-Score	2.39	2.15	1.63	2.65	2.76	7.90	7.16	8.73	10.60	7.79	10.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.71	5.82	6.27	6.92	7.10	2.15	2.29	2.71	3.10	3.24	3.42
Quick Ratio	5.40	5.55	5.99	6.61	6.80	1.82	2.04	2.41	2.76	2.95	3.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.08	-34	-75	-105	-112	-74	-45	-32	-37	-14	-22
Operating Cash Flow to CapEx	-83.78%	281.01%	275.61%	139.49%	-532.21%	-118.16%	13.16%	-48.65%	-365.11%	177.30%	57.93%
Free Cash Flow to Firm to Interest Expense	-2.47	-10.38	-22.66	-31.62	-10.67	-78.75	-48.51	-38.72	-39.07	-14.17	-35.89
Operating Cash Flow to Interest Expense	-2.41	5.79	7.31	3.57	-4.98	-16.97	1.29	-5.50	-32.37	12.41	5.98
Operating Cash Flow Less CapEx to Interest Expense	-5.29	3.73	4.66	1.01	-5.91	-31.34	-8.51	-16.79	-41.24	5.41	-4.34
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.67	0.87	0.83	0.80	0.77	1.12	1.07	1.05	1.01	0.90	0.83
Accounts Receivable Turnover	7.26	8.37	8.79	7.86	7.37	8.85	8.55	8.33	8.20	8.53	6.71
Inventory Turnover	12.97	13.16	12.56	11.79	10.85	11.05	10.65	9.72	9.32	10.17	10.31
Fixed Asset Turnover	5.09	5.16	5.11	5.18	5.28	5.48	5.62	5.80	6.17	6.24	6.08
Accounts Payable Turnover	18.58	28.88	24.33	17.13	18.61	24.64	20.48	21.39	17.70	14.34	20.48
Days Sales Outstanding (DSO)	50.26	43.61	41.55	46.42	49.53	41.27	42.69	43.80	44.50	42.79	54.42
Days Inventory Outstanding (DIO)	28.15	27.74	29.06	30.97	33.65	33.04	34.26	37.53	39.15	35.89	35.39
Days Payable Outstanding (DPO)	19.65	12.64	15.00	21.31	19.61	14.82	17.82	17.06	20.62	25.44	17.83
Cash Conversion Cycle (CCC)	58.76	58.71	55.60	56.08	63.57	59.49	59.13	64.27	63.02	53.23	71.99
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	151	140	136	183	165	108	96	94	80	62	71
Invested Capital Turnover	3.92	4.77	4.81	3.88	4.18	5.80	5.67	5.34	5.68	6.66	5.67
Increase / (Decrease) in Invested Capital	-15	32	40	89	85	47	26	19	9.46	-0.14	7.27
Enterprise Value (EV)	3,352	2,871	2,384	3,432	3,630	3,179	2,759	3,049	3,606	2,642	3,593
Market Capitalization	3,288	2,822	2,319	3,348	3,555	3,281	2,882	3,179	3,748	2,820	3,762
Book Value per Share	$2.76	$2.90	$2.30	$3.19	$2.91	$6.85	$7.19	$7.35	$7.34	$7.96	$7.97
Tangible Book Value per Share	$2.73	$2.88	$2.27	$3.16	$2.88	$6.83	$7.16	$7.32	$7.31	$7.94	$7.94
Total Capital	734	737	718	744	734	245	255	259	257	275	274
Total Debt	647	646	646	645	644	35	35	35	35	35	35
Total Long-Term Debt	647	646	646	645	644	35	35	35	35	35	35
Net Debt	64	49	65	84	75	-102	-124	-130	-141	-178	-169
Capital Expenditures (CapEx)	9.42	6.84	8.83	8.49	9.78	14	9.09	9.40	8.42	7.09	6.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	4.08	-0.65	5.77	18	22	-10	-26	-12	-4.35	-13	-1.28
Debt-free Net Working Capital (DFNWC)	525	535	528	580	591	123	132	153	172	200	202
Net Working Capital (NWC)	525	535	528	580	591	123	132	153	172	200	202
Net Nonoperating Expense (NNE)	7.91	-1.53	11	4.02	19	11	7.79	5.27	11	5.71	6.69
Net Nonoperating Obligations (NNO)	64	49	65	84	75	-102	-124	-130	-141	-178	-169
Total Depreciation and Amortization (D&A)	6.78	7.11	7.15	6.91	6.05	5.06	4.15	4.11	3.80	4.17	0.29
Debt-free, Cash-free Net Working Capital to Revenue	0.66%	-0.11%	1.03%	3.38%	4.19%	-2.10%	-5.60%	-2.66%	-1.01%	-3.28%	-0.34%
Debt-free Net Working Capital to Revenue	84.82%	90.38%	94.25%	107.92%	115.09%	25.06%	27.92%	33.79%	40.00%	48.59%	53.21%
Net Working Capital to Revenue	84.82%	90.38%	94.25%	107.92%	115.09%	25.06%	27.92%	33.79%	40.00%	48.59%	53.21%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.97)	($0.03)	($1.48)	($0.65)	($1.47)	($1.25)	($0.89)	($0.61)	($1.29)	($0.66)	($0.71)
Adjusted Weighted Average Basic Shares Outstanding	31.59M	31.20M	31.26M	31.15M	31.03M	30.53M	30.61M	30.50M	30.30M	29.92M	30.06M
Adjusted Diluted Earnings per Share	($0.97)	($0.03)	($1.48)	($0.65)	($1.47)	($1.25)	($0.89)	($0.61)	($1.29)	($0.66)	($0.71)
Adjusted Weighted Average Diluted Shares Outstanding	31.59M	31.20M	31.26M	31.15M	31.03M	30.53M	30.61M	30.50M	30.30M	29.92M	30.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.93M	31.41M	31.30M	31.24M	31.10M	30.98M	30.65M	30.58M	30.47M	30.22M	30.11M
Normalized Net Operating Profit after Tax (NOPAT)	-23	-2.86	-35	-16	-27	-27	-19	-13	-28	-14	-15
Normalized NOPAT Margin	-14.36%	-1.74%	-23.56%	-10.87%	-20.24%	-20.70%	-15.51%	-10.64%	-24.82%	-12.87%	-14.21%
Pre Tax Income Margin	-18.93%	-0.72%	-31.17%	-13.45%	-34.59%	-29.01%	-21.61%	-14.72%	-35.02%	-17.87%	-20.54%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-9.68	-4.02	-14.76	-5.01	-3.37	-44.78	-29.89	-20.96	-40.08	-20.43	-34.34
NOPAT to Interest Expense	-6.96	-0.86	-10.58	-4.86	-2.55	-29.15	-20.84	-15.88	-29.11	-14.30	-24.04
EBIT Less CapEx to Interest Expense	-12.56	-6.08	-17.41	-7.58	-4.30	-59.15	-39.70	-32.25	-48.94	-27.43	-44.66
NOPAT Less CapEx to Interest Expense	-9.84	-2.92	-13.23	-7.42	-3.49	-43.51	-30.65	-27.17	-37.97	-21.30	-34.35
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-22.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About iRhythm Technologies' Financials

When does iRhythm Technologies's financial year end?

According to the most recent income statement we have on file, iRhythm Technologies' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has iRhythm Technologies' net income changed over the last 9 years?

iRhythm Technologies' net income appears to be on an upward trend, with a most recent value of -$113.29 million in 2024, rising from -$22.80 million in 2015. The previous period was -$123.41 million in 2023. Check out iRhythm Technologies' forecast to explore projected trends and price targets.

What is iRhythm Technologies's operating income?

iRhythm Technologies's total operating income in 2024 was -$115.51 million, based on the following breakdown:

Total Gross Profit: $407.53 million
Total Operating Expenses: $523.04 million

How has iRhythm Technologies revenue changed over the last 9 years?

Over the last 9 years, iRhythm Technologies' total revenue changed from $36.14 million in 2015 to $591.84 million in 2024, a change of 1,537.6%.

How much debt does iRhythm Technologies have?

iRhythm Technologies' total liabilities were at $840.54 million at the end of 2024, a 276.8% increase from 2023, and a 1,882.4% increase since 2015.

How much cash does iRhythm Technologies have?

In the past 9 years, iRhythm Technologies' cash and equivalents has ranged from $0.00 in 2017 to $419.60 million in 2024, and is currently $419.60 million as of their latest financial filing in 2024.

How has iRhythm Technologies' book value per share changed over the last 9 years?

Over the last 9 years, iRhythm Technologies' book value per share changed from -73.85 in 2015 to 2.90 in 2024, a change of -103.9%.

Related Companies

This page (NASDAQ:IRTC) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Financials

Frequently Asked Questions About iRhythm Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Financials

Annual Income Statements for iRhythm Technologies

Quarterly Income Statements for iRhythm Technologies

Annual Cash Flow Statements for iRhythm Technologies

Quarterly Cash Flow Statements for iRhythm Technologies

Annual Balance Sheets for iRhythm Technologies

Quarterly Balance Sheets for iRhythm Technologies

Annual Metrics And Ratios for iRhythm Technologies

Quarterly Metrics And Ratios for iRhythm Technologies

Frequently Asked Questions About iRhythm Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools